Scientists working with adult stem cells in laboratory animals have developed a technique that allows them to influence the fate of cells within the natural brain environment.
- Follow @mslogs
Discussion
HOME
Links
Shop
Stories
-
Scientists working with adult stem cells in laboratory animals have developed a technique that allows them to influence the fate of cells within the natural brain environment.
Laqininimod, a pill from Teva Pharmaceuticals has shown enough promise and safety in the treatment of relapsing remitting multiple sclerosis that the manufacturer is now preparing the product for a phase 3 study. No oral disease modifying therapy has made it past this phase in the drug trial stages, although a “cousin” of Laquinimod did survive until phase 3 when the drug was discovered to have adverse effects on the heart.
Microsoft has a column with tips for persons with multiple sclerosis that can enable them to use Microsoft Office products more effectively.
MyMSmyWay has links to freeware and other suggestions for making life with you computer more productive.
A small double blind study of Prozac therapy for multiple sclerosis has concluded with a reduction of neurological inflammation for the group recieving the active medication. The results suggest further study.
Studies have shown that the Novartis compound called FT720 has shown a high effectiveness for stopping exacerbations for up to 75 % of multiple sclerosis patients after three years in an extended clinical trial. The medicine is a once a day pill that would be a more palatable alternative to the injectable therapies that are commonplace for treating MS presently.
There were hopes that the drug Rituxin might benefit multiple sclerosis patients with the primary progressive stage of the disease, but a long term study of the therapy failed to produce a significant benefit.
The firm devoloping brochures and informational materials for a multiple sclerosis clinical trial wants your thoughts on design and suggestions on content. If you are interested please visit the post in the forum by clicking here.
A new drug that has been proven effective against auto immune disease in mice is now being studied in humans with multiple sclerosis to determine if the same positive results can be achieved.
UT Southwestern scientists are using a special suit that delivers heating or coooling to MS patients and then observing the resulting effects on vision, The results may help develop and determine therapies for heat related symptoms in multiple sclerosis.
Treatment Investigations
In an effort to determine why treatments are successful for some multiple sclerosis patients but not all, researchers have identified certain types of inflammatory responses in lab animals and are investigating different agents to determine the best treatments based on cause of the inflammation.